Skip to Main Content

A pair of top House Democrats is investigating whether Emergent BioSolutions (EBS), which was responsible for contaminating millions of doses of the Johnson & Johnson (JNJ) Covid-19 vaccine, traded on its relationship with a key Trump administration official to win federal contracts.

In a letter to the company, the lawmakers noted they are reacting to reports that Emergent received a $628 million contract last June to create the main U.S. facility for making Covid-19 vaccines for both J&J and AstraZeneca (AZN), despite a history of inadequately trained staff and quality control problems.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!